Stocksigma LogoStocksigma Logo

Neuland Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 44,966 (-12.6% YoY | -29.9% QoQ) ■ EBITDA: 9,756 (-37.3% YoY | -56.2% QoQ) ■ EBITDA Margin (%): 21.7 (-855 bps YoY | -1304 bps QoQ) ■ PAT: 5,163

Neuland Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

Neuland Laboratories Ltd · Outcome · 03 Nov 2026, 9:18 pm

Neuland Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 44,966 (-12.6% YoY | -29.9% QoQ) ■ EBITDA: 9,756 (-37.3% YoY | -56.2% QoQ) ■ EBITDA Margin (%): 21.7 (-855 bps YoY | -1304 bps QoQ) ■ PAT: 5,163 (-46.7% YoY | -65.0% QoQ) ■ EPS (INR): 40.2 (-46.7% YoY | -65.0% QoQ)

Original exchange filing (PDF)

More announcements from Neuland Laboratories Ltd

All Neuland Laboratories Ltd announcements